[Federal Register Volume 87, Number 85 (Tuesday, May 3, 2022)]
[Notices]
[Pages 26202-26203]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-09495]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Healthcare Infection Control 
Practices Advisory Committee (HICPAC). This virtual meeting is open to 
the public, limited only by the number of audio and web conference 
lines (300 audio and web conference lines are available). Time will be 
available for public comment. Registration is required.

DATES: The meeting will be held on June 2, 2022, from 12:00 p.m. to 
2:30 p.m., EDT.

ADDRESSES: To register for this web conference, please go to: 
www.cdc.gov/hicpac. All registered participants will receive the 
meeting link and instructions shortly before the meeting. Please click 
the link below to join the webinar: https://cdc.zoomgov.com/

[[Page 26203]]

webinar/register/WN_YfMgXEbaQQ6OGOiVHIA5pA.
    Meeting ID: 161 839 6503.
    Passcode: 31085109.

FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., Program Analyst, 
HICPAC, Division of Healthcare Quality Promotion (DHQP), National 
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), CDC, 
1600 Clifton Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027, 
Telephone: (404) 718-8039; Email: <a href="/cdn-cgi/l/email-protection#95dddcd6c5d4d6d5f6f1f6bbf2fae3"><span class="__cf_email__" data-cfemail="b1f9f8f2e1f0f2f1d2d5d29fd6dec7">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION:
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, DHQP; the Director, NCEZID; the Director, 
CDC; and the Secretary, Department of Health and Human Services, 
regarding (1) the practice of healthcare infection prevention and 
control; (2) strategies for surveillance, prevention, and control of 
infections, antimicrobial resistance, and related events in settings 
where healthcare is provided; and (3) periodic updating of CDC 
guidelines and other policy statements regarding prevention of 
healthcare-associated infections and healthcare-related conditions.
    Matters to be considered: The agenda will include the following 
updates: The Healthcare Personnel Guideline Workgroup; Isolation 
Precautions Guideline Workgroup; and Neonatal Intensive Care Unit 
Workgroup. Agenda items are subject to change as priorities dictate.

Public Participation

    Oral Public Comment: Time will be available for public comment. 
Members of the public who wish to provide public comments should plan 
to attend the public comment session at the start time listed. Please 
note that the public comment period may end before the time indicated, 
following the last call for comments.
    Written Public Comment: The public may submit written comments in 
advance of the meeting. Comments should be submitted in writing by 
email to the contact person listed above. The deadline for receipt of 
written public comment is May 23, 2022. All requests must contain the 
submitter's name, address, and organizational affiliation, as well as 
the topic being addressed. Written comments should not exceed one 
single-spaced typed page in length. Written comments received in 
advance of the meeting will be included in the official record of the 
meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-09495 Filed 5-2-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>